MichaelGrimleyMD

PubMed

• 5 citations
  Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy.
  Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas
  Blood Advances. 2020-07-28
• 279 citations
  Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.
  Sonata Jodele, Stella M. Davies, Adam Lane, Jane C. Khoury, Christopher E. Dandoy
  Blood. 2014-07-24
• 107 citations
  Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
  Benjamin Watkins, Muna Qayed, Courtney McCracken, Brandi Bratrude, Kayla Betz
  Journal of Clinical Oncology. 2021-01-15

Journal Articles

• Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults  
  Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL, Blood, 1/29/2014
• Secondary Hemophagocytic Lymphohistiocytosis (HLH) from a Presumed Brown Recluse Spider Bite  
  Dandoy C, Grimley M, J Clin Immunol, 1/16/2014
• Pediatric acute liver failure and immune dysregulation  
  DiPaola F, Grimley M, Bucuvalas J, J Pediatr, 1/1/2014
• The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients  
  Khandelwal P1, Lawrence J, Filipovich AH, Davies SM, Bleesing JJ, Jordan MB, Mehta P, Jodele S, Grimley MS, Kumar A, Myers K, Marsh RA, Pediatr Transplant, 1/1/2014
• An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophago...  
  Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley M, Kumar A, Jodele S, Myers KC, Chandra S, Leemhuis T, Mehta PA, Bleesing JJ, Davies SM. Jordan MB, Filipovich AH, Biol Blood Marrow Transplant, 1/1/2013
• Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transp...  
  Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, ..., Biol Blood Marrow Transplant, 1/1/2012
• Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Eurocord and Inborn Errors Working Party of European Group for Blood and ...  
  Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR, Friedrich W, Porta F, Diaz de Heredia C, Wall D, Bertrand Y, Veys P, Slatter M, Schulz A, Chan KW, Gr..., Blood, 1/1/2012
• Engraftment of unrelated cord blood after reduced-intensity regimen in children with refractory neuroblastoma: a feasibility study  
  Jubert C, Wall DA, Grimley M, Champagne MA, Duval M, Bone Marrow Transplant, 1/3/2010
• Mycophenolate pharmcokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network  
  Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D, Biol. Blood Marrow Transplant, 1/1/2010
• Reduced intensity allogeneic transplantation in pediatric patients ineligible for myeloabalative therapy: results of the Pediatric Blood and Marrow Transplant Consorti...  
  Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK, Shaw PJ, Haight AE, Grimley M, Grupp SA, Kletzel M, Kadota R, Blood, 1/13/2009
• Evaluation of Pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: A Pediatric Blood and Marrow Transplant Consortium Study  
  Jacobsohn DA, Gilman A, Rademaker A, Browning B, Grimley M, Lehman L, Nemecek E, Thormann K, Schultz K, Vogelsang G, Blood, 1/12/2009
• The use of Sirolimus to prevent relapse after allogeneic hematopoietic cell transplantation in Pediatric ALL: Results of a prospective multi-institutional trial  
  Pulsipher MA, Wall D, Grimley M, Goyal RK, Boucher K, Hankins P, Grupp SA, Bunin N, British Journal of Hematology, 1/1/2009
• Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia  
  Chan KW, McDonald L, Lim D, Grimley MS, Grayson G, Wall DA, Bone Marrow Transplant, 1/1/2008
• Early identification and management of graft failure after unrelated donor cord blood transplantation  
  Chan KW, Grimley MS, Taylor C, Wall DA, Bone Marrow Transplant, 1/1/2008
• Familial Childhood Leukemia Cluster with Multiple Aggressive Early-Onset Hematological Malignancies  
  Swinney RM, Wall D, Thomas P, Grimley M, Taylor C, Tomlinson GE, Leuk Lymphoma, 1/1/2006
• Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease  
  Shaughnessy PJ, Bachier C, Grimley M, Freytes CO, Callander NS, Essell JH, Flomenberg N, Shelby G, LeMaistre CF, Biol Blood Marrow Transplant, 1/1/2005
• Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Labe...  
  Walsh T, Bachier C, Shaughnessy P, Freytes C, Callander N, LeMaistre CF, Grimley M, Bradshaw P, Blood, 1/1/2004
• Eukaryotic Initiation Factor 4E Staining as a Clinical Marker in Pediatric Neuroblastoma  
  Parker A, Anderson C, Lancaster-Weiss K, Grimley M, Sorrells D, Journal of Pediatric Hematology/Oncology, 1/1/2004
• Comparison of Enhanced Magnetic Resonance Imaging with Renal Cortical Scintigraphy in the Diagnosis of Childhood Pyelonephritis  
  Lonergan GL, Pennington DJ, Morrison JC, Haws RM, Grimley MS, Kao TC, Radiology, 1/1/1998
• Join now to see all

Books/Book Chapters

• Clinical Oncology 
  Chapter: Immunodeficiency and cancer. 
  Page 200 - 213Filipovich AH, Grimley MSEditors: MD Abeloff et al.Churchill Livingstone Inc, New York City, NYEdition 2nd,2000

Abstracts/Posters

• Prenatal Origin Of Monosomy 7 In Very Young Children.
  Mehta P, Wunderlich M, Smolarek S, Davies S, Zimmerman S, Filipovich A, Broxson E, Grimley M, Cancelas J, Mulloy J, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoieti...
  Marsh RA, Kim MO. Liu C, Bellman D, Hart L, Jordan MB, Bleesing JJ, Mehta PA, Jodele S, Myers KC, Kumar A, Grimley M, Davies SM, Filipovich AH, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease.
  Khandelwal P, Mellor-Heinke S, Davies SM, Grimley M, Bleesing J, Jordan M, Jodele S, Marsh R, Mehta P, Myers KC, Rehman N, Smiley K, Villanueva J, Filipovich AH, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Immune Reconstitution Following Reduced Intensity Stem Cell Transplant for Non-malignant Disorders.
  Bednarski, JJ, Le C, Murray L, Hayashi R, Yu L, Dalal J, Kamani N, Jacobsohn D, Pulsipher M, Petrovic A, Chan KW, Grimley M, Haut P, Adams R, Douglas D, Chaudhury S, G..., Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Alemtuzumab as Therapy for Mixed Chimerism after Hematopoietic Stem Cell Transplant for Fanconi Anemia (FA).
  Chandra S, Grimley M, Davies SM, Myers KC, Khandelwal P, Zhang K, Mehta P, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Secondary Hemophagocytic Lymphohistiocytosis (HLH) From a Brown Recluse Spider Bite.
  Dandoy C, Grimley M, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Clinical utility of Diagnostic Criteria for Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA): A Prospective Single Center study. B...
  Jodele S, Khoury J, Goebel J, Zahner M, Kennedy R, Kinsella T, Grimley M, Davies SM, Laskin B, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Reduced Intensity Hematopoietic Cell Transplant for Non-Fanconi Anemia Marrow Failure Syndromes.
  Mehta PA, Marsh RA, Kim MO, Myers KC, Bellman D, Bleesing JJ, Chandra S, Filipovich AH, Grimley M, Jodele S, Jordan M, Kumar A, Harris M, Ball K, Davies SM, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Alternate Day Micafungin Antifungal Prophylaxis in High Risk Pediatric Patients Undergoing Hematopoietic Cells Transplantation (HSCT). Biology of Blood and Marrow Tran...
  Chandra S, Davies SM, Filipovich AH, Bleesing JJ, Grimley M, Jodele S, Jordan M, Kumar A, Marsh RA, Myers KC, Tarin R, Edwards SL, Mehta P, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Incidence and Outcomes of Fungal Infections in Children Undergoing Allogeneic Stem Cell Transplantation (HCT): Eight Years Single Center Experience. Biology of Blood a...
  Wallace G, Davies SM, Filipovich AH, Connelly B, Cloughessy M, Bleesing JJ, Chandra S, Grimley M, Jodele S, Jordan M, Kumar A, Marsh RA, Myers KC, Bellman D, Mehta PA, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience.
  Chandrakasan S, Marsh RA, Bellman D, Grimley M, Bleesing JJ, Jordan MB, Davies SM, Filipovich AH, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute GVHD in Patients with HLH and XLP Undergoing Allogeneic HCT.
  Marsh RA, Kim MO, Bellman D, Hart L, Jordan MB, Bleesing JJ, Mehta PA, Jodele S, Myers KC, Kumar A, Grimley M, Davies SM, Filipovich AH, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
• CMX001 is a potential treatment for Adenovirus infection: preliminary antiviral activity results from an open-label, expanded access study of CMX001 for the treatment ...
  Grimley M, Papanicolaou G, Prasad V, Dropulic, Mommeja-Marin H, Brundage T, Chittick G, Margolskee D, EBMT Annual Meeting, 1/1/2013
• Secondary Hemophagocytic Lymphohistiocytosis (HLH) From a Brown Recluse Spider Bite.
  Dandoy C, Grimley M, Biology of Blood and Marrow Transplantation; CIS Annual Meeting, Miami, FL, 1/1/2013
• A Novel 14 day Reduced Intensity Conditioning Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Allogeneic Hematopoietic Cell Transplantation of ...
  Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley MS, Mehta PA, Kumar A, Jodele S, Myers KC, Bleesing JJ, Davies SM, Jordan MB, Filipovich AH, CIS Annual Meeting, Miami, FL, 1/1/2013
• Secondary Hemophagocytc Lymphohistiocytosis (HLH) From A Brown Recluse Spider Bite.
  Dandoy C, Grimley M, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• Alemtuzumab As Therapy For Mixed Chimerism After Hematopoietic Stem Cell Transplantation For Fanconi Anemia.
  Chandra S, Grimley M, Davies S, Myers K, Khandelwal P, Zhang K, Mehta P, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• Utility Of Current Diagnostic Criteria For Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Prospective Single Institution Study.
  Jodele S, Davies S, Khoury J, Goebel J, Zahner M, Kinsella T, Grimley M, Myers K, Mehta P, Bleesing J, Filipovich A, Marsh R, Kumar A, Jordan M, Laskin B, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• CD38 Bright Effector Memory CD8+ T CELL Populations Predict Acute Graft Versus Host Disease And Also Graft Rejectio.
  Khandelwal P, Chaturvedi V, Jordan M, Marmer D, Owsley E, Davies S, Bleesing J, Filipovich A, Chandra S, Jodele S, Grimley M, Myers K, Kumar A, Marsh R, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• Reduced Intensity Hematopoietic Cell Transplantation For Non-Fanconi Anemia Marrow Failure Syndromes.
  Mehta P, Marsh R, Kim M, Myers K, Bellman D, Bleesing J, Chandra S, Filipovich A, Grimley M, Jodele S, Jordan M, Kumar K, Harris M, Ball K, Davies S, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• Alternate Day Micafungin Antifungal Prophylaxis In High Risk Pediatric Patients Undergoing Hematopoietic Cell Transplantation.
  Chandra S, Davies S, Filipovich A, Bleesing B, Grimley M, Jodele S, Jordan J, Kumar A, Marsh R, Myers K, Tarin R, Edwards S, Mehta P, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• Engraftment Syndrome has Distinct Biology Compared to Acute Graft Versus Host Disease.
  Khandelwal P, Mellor-Heinke S, Davies S, Grimley M, Bleesing J, Jodele S, Marsh R, Mehta P, Jordan M, Myers K, Rehman N, Smiley K, Villanueva J, Filipovich A, Pediatric Blood & Cancer; ASPHO Annual Meeting, Miami, FL, April 2013, 1/1/2013
• Adolescents and Young Adults with Hemophagocytic Lymphohistiocytosis who Undergo Allogeneic Hematopoietic Cell Transplantation are at Increased Risk of Mortality Compa...
  Chandrakasan S, Marsh R, Grimley M, Bleesing J, Jordan M, Filipovich AH, Blood; ASH, 1/1/2013
• The First Interventional Trial for Adenovirus (AdV): Brincidofovir (CMX001) for ADV in HCT.
  Grimley M, Chemaly R, Englund J, Yu L, Brundage T, Mommeja-Marin H, Kurtzberg J, ICAAC, Denver, CO, 1/1/2013
• Allogeneic Transplantation foe X-Linked Hyper IgM Syndrome-A Single Instution Experience.
  Chandra S, Bleesing JJ, Davies SM, Jordan MB, Marsh R, Mehta P, Jodele S, Grimley MS, Kumar AR, Myers KC, Johnson J, Zhang K, Filipovich AH, CIS Annual Meeting, Miami, FL, 1/1/2013
• Join now to see all

Lectures

• Department of Pediatric Grand Rounds: "Hematopoietic Stem Cell Therapy for Sickle cell Disease: Current Practice and Emerging Trends" 
  University of Kentucky Children's Hospital, Lexington, KY - 1/1/2013
• "Bone Marrow Transplant for Inherited Bone Marrow Failure Syndromes and Primary Immunodeficiencies" 
  1/1/2013
• "Bone Marrow Transplant for Sickle Cell Disease: Current Practice and Emerging Trends" 
  1/1/2013
• Department of Pediatrics Grand Rounds/CPC: "Wiskott-Aldrich Syndrome" 
  Cincinnati Children's Hospital Medical Center - 1/1/2012
• "Complications of SCT-VOD and IPS" 
  San Antonio, TX - 1/1/2010
• Department of Pediatrics Grand Rounds: "Stem Cell Transplant for Primary Immunodefiencies" 
  Wilford Hall Medical Center, Lackland AFB, TX - 1/1/2009
• Keynote Speaker: "2009 Marrow Donor Appreciation Reception" 
  1/1/2009
• "Primary Immunodefiencies in Pediatrics" 
  San Antonio, TX - 1/1/2008
• Pediatric Grand Rounds: "Pediatric Stem Cell Transplantation" 
  Driscoll Children's Hospital, Corpus Christi, TX - 1/1/2007
• "Fundamental Principles of Blood and Marrow Transplantation" 
  San Antonio, TX - 1/1/2007
• "Engraftment/Immune Reconstruction" 
  San Antonio, TX - 1/1/2007
• "Meet the Doctor: Stem Cells/Bone Marrow Transplant for Adults and Children" 
  IBC Bank, McAllen, TX - 1/1/2007
• "Common Issues in Pediatric Peripheral Stem Cell Apheresis" 
  San Antonio, TX - 1/1/2006
• Department of Allergy/Immunology Grand Rounds: "Bone Marrow Transplant for Primary Immunodeficiencies" 
  Wilford Hall Medical Center, Lackland AFB, TX - 1/1/2005
• "Indications for Pediatric Stem Cell Transplant" 
  El Paso, TX - 1/1/2005
• "Pediatric Stem Cell Transplantation: Nuts and Bolts" 
  Austin, TX - 1/1/2004
• Join now to see all

Other

• Diamond-Blackfan Anemia. 
  Shelton JB, Neuhauser TN, Grimley MS, Diamond-Blackfan Syndrome, Check Sample